Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome

Seminars in Hematology
Fadi Fakhouri, Chantal Loirat

Abstract

The dissection of the pathogenic mechanisms of the various forms of the hemolytic uremic syndrome (HUS) has paved the way for the design of specific efficacious treatments. Such mechanistic approach led to a revolution in the management of atypical HUS with the use of the first-in class C5 blocker, eculizumab. The availability of this anticomplement drug has also raised unsettled questions regarding the cost or burden and optimal duration of therapy and its use in secondary HUS. The efficacy of eculizumab in Shiga toxin producing Escherichia coli-associated HUS is not to date established and the results of ongoing prospective studies are eagerly awaited. Nevertheless, the emergence of anticomplement therapies (eculizumab and other drugs in development) has transformed our approach of HUS.

Citations

Dec 28, 2019·PloS One·R I KushakE F Grabowski
Jan 1, 2018·Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V·Wouter J C FeitzChristoph Licht
Apr 17, 2020·Frontiers in Cellular and Infection Microbiology·Clifford Lingwood
Jul 28, 2020·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Verena KlämbtKarsten Häffner
Nov 8, 2018·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Kioa L WijnsmaNicole C A J van de Kar
Apr 17, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Arvind BaggaUNKNOWN Indian Society of Pediatric Nephrology
Feb 6, 2020·Indian Journal of Nephrology·Tomoo KiseMasatsugu Uehara
Jan 30, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gema Ariceta
Dec 5, 2020·Indian Journal of Nephrology·Malsawmkima Chhakchhuak, Jony Agarwal
Jun 29, 2021·AJP Reports·Sara Madureira GomesHelena Pinto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Alex DinhLisa M Rubin
Nihon Jinzo Gakkai shi
Toshihiro SawaiTomoyuki Sakai
La Presse médicale
Chantal LoiratMartin Bitzan
© 2022 Meta ULC. All rights reserved